文献速递肿瘤 PET/CT

FAPI PET/MRI评估子宫内膜异位症范围初探

Initial Results of FAPI PET/MRI to Assess the Extent of Endometriosis.
PubMed 文献 · J Nucl Med · 2026-08-03

本研究回顾性纳入18例绝经前女性,其中9例疑似或确诊子宫内膜异位症患者接受[68Ga]BED003 FAPI PET/MRI或PET/CT,另9例无已知子宫内膜异位症的乳腺癌分期患者作为参考队列。基于#Enzian分类的节段分析显示,联合PET/MRI在49%的节段中识别出可疑病灶,而单独MRI仅19%;测试队列宫外局灶性FAP摄取节段比例(41%)显著高于参考队列(13%,P<0.01)。结论认为FAPI PET/MRI较单独MRI提高了子宫内膜异位症可疑病灶的检出率。

要点

  • FAPI PET/MRI较单独MRI提高子宫内膜异位症可疑病灶检出(49% vs 19%节段)。
  • 测试队列宫外局灶FAP摄取节段比例显著高于参考队列(41% vs 13%)。
  • PET/MRI所见与腹腔镜结果显示高度一致性。

核心结论

  • FAPI PET/MRI较单独MRI增加了子宫内膜异位症可疑病灶的检出。
  • 结果支持进一步前瞻性评估FAPI PET/MRI作为术前评估的辅助影像手段。

研究设计与样本

  • 回顾性研究,纳入18例绝经前女性,测试队列9例疑似或确诊子宫内膜异位症,参考队列9例无已知子宫内膜异位症的乳腺癌分期患者。
  • 测试队列使用[68Ga]BED003 FAPI PET/MRI或PET/CT,参考队列使用[68Ga]BED003或[68Ga]Ga-FAPI-46。
  • 检查未按月经周期安排,采用基于#Enzian分类的节段分析,以临床评估和可获得的腹腔镜结果为参考标准。

主要发现

  • 在有PET/MRI数据的测试队列(7例、91个节段)中,单独MRI识别19%节段为子宫内膜异位症可疑,联合PET/MRI为49%。
  • 全部PET数据集(每队列108个节段)中,测试队列41%节段见宫外局灶性FAP摄取,参考队列为13%(P<0.01)。
  • 测试队列每例患者PET阳性节段均数高于参考队列(4.9±2.4 vs 1.7±1.3,P=0.009),差异以腹膜、卵巢和输卵管节段最明显。
  • 两队列子宫SUVmax无显著差异(P=0.489)。
  • 可获得的PET/MRI结果与腹腔镜结果显示高度一致性。

临床怎么用

  • FAPI PET/MRI可作为子宫内膜异位症术前评估的辅助影像手段,补充常规经阴道超声和MRI对深部浸润病灶的低估。

局限性

  • 回顾性设计,样本量小(测试队列9例,有PET/MRI数据者7例)。
  • 检查未按月经周期安排。
  • 参考队列为乳腺癌分期患者而非健康对照。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Endometriosis is a common gynecologic disorder often associated with chronic pelvic pain, infertility, and reduced quality of life. Conventional imaging modalities, such as transvaginal ultrasound and MRI, may underestimate the extent of disease, particularly in deep infiltrating endometriosis. Fibroblast activation protein (FAP) is highly expressed in remodeling endometrium and has been implicated in endometriotic lesions. This study investigates the feasibility of integrating FAP-targeted PET/MRI to improve endometriosis detection. Methods: This retrospective study included 18 premenopausal women. The test cohort consisted of 9 patients with suspected or confirmed endometriosis who had undergone FAP-targeted PET/MRI or PET/CT with the FAP inhibitor (FAPI) [68Ga]BED003 (previously known as [68Ga]Ga-OncoFAP-DOTAGA). The reference cohort consisted of 9 premenopausal women without known endometriosis who had undergone FAPI PET/MRI or PET/CT with either [68Ga]BED003 or [68Ga]Ga-FAPI-46 for initial staging of breast cancer. Examinations were not scheduled with regard to the patients' menstrual cycles. Lesions were assessed using a segment-based analysis derived from the #Enzian classification. Focal radiopharmaceutical uptake was semiquantitatively assessed using SUVmax and SUVmean Clinical assessments and laparoscopic findings, when available, served as reference standards. Results: In the test cohort with available PET/MRI data (7 patients and 91 segments), MRI alone identified endometriosis-suspicious findings in 19% of segments. In contrast, combined PET/MRI identified findings in 49% of segments. Among all PET datasets (108 segments per cohort), focal extrauterine FAP uptake was observed in 41% of the test cohort's segments compared with 13% of the reference cohort's segments (P < 0.01). The mean number of PET-positive segments per patient was higher in the test cohort than in the reference cohort (4.9 ± 2.4 vs. 1.7 ± 1.3, P = 0.009), with the greatest difference observed in peritoneal, ovarian, and tubal segments. Uterine SUVmax did not differ significantly between the 2 cohorts (P = 0.489). Where available, PET/MRI findings showed substantial concordance with laparoscopic results. Conclusions: FAPI PET/MRI increased the detection of lesions suggestive of endometriosis compared with MRI alone. These findings support further prospective evaluation of FAPI PET/MRI as an adjunct imaging modality for preoperative assessment of endometriosis.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Schindler P, Brandt J, Bobe S, et al. Initial Results of FAPI PET/MRI to Assess the Extent of Endometriosis. J Nucl Med. 2026. PMID: 42242866. doi:10.2967/jnumed.125.271376

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。